Fecal Microbiota Transplantation vs Placebo in Allogeneic HCT Recipients and Patients With AML
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Randomized Double-Blind Phase II Trial of Fecal Microbiota Transplantation Versus Placebo in Allogeneic Hematopoietic Cell Transplantation and AML
J. Clin. Oncol 2023 May 26;[EPub Ahead of Print], A Rashidi, M Ebadi, TU Rehman, H Elhusseini, D Kazadi, H Halaweish, MH Khan, A Hoeschen, Q Cao, X Luo, AJ Kabage, S Lopez, SG Holtan, DJ Weisdorf, A Khoruts, C StaleyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.